https://www.selleckchem.com/products/AZD0530.html
Academic respondents were more likely to prescribe an anti-estrogen medication to symptomatic patients and prophylactically(p less then 0.05). Anastrozole was the most common medication prescribed for symptomatic hyperestrogenemia (62.3%), but starting doses varied significantly, from 1mg weekly to 1mg daily. CONCLUSIONS Approximately 50% of practitioners treating men with TTh monitor estrogen levels. Symptoms play a role in prescribing patterns and significant variability in aromatase inhibitors regimens exists. Increased monitoring of